September 2019

Screening US after digital mammography, DBT | Boosting trainee confidence | FDA approvals ()
Week in Review: What radiology can learn from the service industry | AI interprets images as well as physicians ()
Editor's Choice: 10 Important Stories from September ()
AI interprets images as well as physicians—but there’s a catch | Comfort during mammograms | Responding to angry patients ()
Fast MRI scans ID brain injuries in young patients | How to drop operating room times, bolster bottom line ()
Healthcare Economics | September 2019 ()
A ‘nudge’ in the right direction can improve cancer screening | Lung-RADS classifications | Big news from Mount Sinai ()
Are radiologists unhappy with the ABR MOC program? | How to improve state-mandated breast density notifications ()
Week in Review: A new Q&A on error disclosure | Potential unhappiness with the ABR | ProScan accused of fraud ()
Screening mammography for men | Exposed medical data | More from ASTRO 2019 ()
A key difference between synthetic mammography, FFDM | ACR acquires searchable database for patient use ()
Q&A: Stephen D. Brown on the prospect of radiologists disclosing errors to patients | News from ASTRO 2019 ()
Imaging Informatics | September 2019 ()
How updated recruitment efforts can improve diversity in radiology | New MRI technique predicts dementia ()
Week in Review: What is RI-RADS? | Implementing standardized imaging protocols | Imaging for breast pain ()
Nonphysician providers interpreting more imaging exams | How to reduce radiation exposure during CT scans ()
Leadership | September 2019 ()
Improving patient adherence to lung cancer screening recommendations | Vaping linked to severe lung disease ()
Artificial Intelligence | September 2019 ()
AI searches radiology reports for follow-up recommendations | Radiation oncologist could soon lead FDA ()
Policy | September 2019 ()
Imaging utilization continues to rise—should that be viewed as a negative? | Ethical guidelines for AI in healthcare ()
Radiologists ready to speak | USPSTF on breast cancer medications | Allergic reactions to CT contrast agents ()